CHANG NANCY T enters IMMIX BIOPHARMA, INC. with 918.88K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 9/17/2025ACC: 0001493152-25-013834
918.88K
Baseline shares
46% direct
421.94K
Direct ownership
1 position
632.91K
Derivative underlying
2 instruments
2
Security positions
496.94K indirect
Non-Derivative Holdings2
Common Stock
DirectShares owned421.94K
Common Stock
IndirectShares owned496.94K
Total
421.94K direct·496.94K indirect918.88K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 421.94K | Direct |
| Common Stock | 496.94K | Indirect |
| Total | 918.88K | 421.94K direct·496.94K indirect |
Derivative Holdings2
Non-Transferrable Warrant to Purchase Common Stock
DirectUnderlying security
Common Stock
Underlying shares
316.45K
Shares owned
N/A
Exercise price
2.00
Expiration
—
Exercise window
—
Non-Transferrable Warrant to Purchase Common Stock
IndirectUnderlying security
Common Stock
Underlying shares
316.45K
Shares owned
N/A
Exercise price
2.00
Expiration
—
Exercise window
—
Total
Underlying
632.91K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Non-Transferrable Warrant to Purchase Common Stock Direct | Common Stock | 2.00 | — | — | 316.45K | N/A |
| Non-Transferrable Warrant to Purchase Common Stock Indirect | Common Stock | 2.00 | — | — | 316.45K | N/A |
| Total | 632.91K | 0.00 | ||||